Global Non-Small Cell Lung Cancer (NSCLC) market size is expected to reach $33.29 billion by 2029 at 10.5%, segmented as by squamous cell carcinoma, keratinizing squamous cell carcinoma, non-keratinizing squamous cell carcinoma
Read MoreGlobal Non-Emergency Medical Transportation market size is expected to reach $13.74 billion by 2029 at 7.7%, segmented as by courier services, medical supply delivery, prescription delivery, laboratory specimen transport
Read MoreGlobal Neurotrophic Keratitis Treatment market size is expected to reach $7.39 billion by 2029 at 7.6%, segmented as by topical antibiotics, broad-spectrum antibiotics, narrow-spectrum antibiotics
Read MoreGlobal Neuropathic Pain market size is expected to reach $7.76 billion by 2029 at 7.6%, segmented as by medications, anticonvulsants, antidepressants, opioids, topical treatments, non-steroidal anti-inflammatory drugs (nsaids)
Read MoreGlobal Neurofibromatosis Treatment market size is expected to reach $24.54 billion by 2029 at 13.2%, segmented as , surgical interventions, medication for symptom management, genetic counseling
Read MoreGlobal Neuralgia Treatment market size is expected to reach $3.13 billion by 2029 at 6.4%, segmented as by drug based, anticonvulsants, antidepressants, opioids, topical treatments, non-steroidal anti-inflammatory drugs (nsaids)
Read MoreGlobal Nasopharyngeal Carcinoma Treatment market size is expected to reach $1.69 billion by 2029 at 6.9%, segmented as by non-keratinizing undifferentiated carcinoma, poorly differentiated type, well-differentiated type
Read MoreGlobal Myelodysplastic Syndrome market size is expected to reach $4.17 billion by 2029 at 10%, segmented as by myelodysplastic syndrome with unilineage dysplasia, type of dysplasia, patient demographics
Read MoreGlobal Muscle Wasting Disorders market size is expected to reach $29.67 billion by 2029 at 14.1%, segmented as by medications, anabolic steroids, hormonal treatments, anti-inflammatory drugs, immunomodulatory agents
Read MoreGlobal MRI Contrast Media market size is expected to reach $2.11 billion by 2029 at 6.1%, segmented as by extracellular contrast agents, gadolinium-based contrast agents (gbca), non-gadolinium-based contrast agents
Read More